UnitedHealth Group Inc faces uncertainty as President Trump pushes for healthcare policy changes by Jan. 30, 2026. The company is cutting broker commissions on Medicare Advantage plans and dealing with a DOJ probe into Medicare billing practices. Despite challenges, UNH reported strong Q3 earnings with $113.2 billion in revenue and a 2.1% margin. Warren Buffett’s Berkshire Hathaway bought 5 million shares of UNH, signaling confidence in the company’s resilience. Analysts estimate a YOY earnings decline for Q4 2025 and Q1 2026, but UnitedHealth raised its 2025 outlook. Wall Street analysts maintain a “Moderate Buy” rating with a price target of $388.64, suggesting an 18.8% upside potential. With scale, cash flow, and growth prospects, UNH is positioned for potential upside in 2026 amidst policy uncertainties.

Read more at Barchart: Dear UnitedHealth Stock Fans, Mark Your Calendars for January 30